All Publications

Journals

• Furze RC; Rankin SM. (Sep 2008). The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse. FASEB J. 22:3111-3119. DOI.
• Rankin SM. (Jun 2008). Impact of bone marrow on respiratory disease. CURR OPIN PHARMACOL. 8:236-241. DOI.
• Burdon PCE; Martin C; Rankin SM. (Jul 2008). Migration across the sinusoidal endothelium regulates neutrophil mobilization in response to ELR plus CXC chemokines. BRIT J HAEMATOL. 142:100-108. DOI.
• Wengner AM; Pitchford SC; Furze RC; Rankin SM. (10 Oct 2007). The co-ordinated action of G-CSF and ELR+CXC chemokines in neutrophil mobilisation during acute inflammation. Blood. DOI.
• Martin C; Burdon PC; Bridger G; Gutierrez-Ramos JC; Williams TJ; Rankin SM. (Oct 2003). Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity. 19:583-593.
• Burdon PC; Martin C; Rankin SM. (15 Mar 2005). The CXC chemokine MIP-2 stimulates neutrophil mobilization from the rat bone marrow in a CD49d-dependent manner. Blood. 105:2543-2548. DOI.
• Watanabe K; Jose PJ; Rankin SM. (15 Feb 2002). Eotaxin-2 generation is differentially regulated by lipopolysaccharide and IL-4 in monocytes and macrophages. J Immunol. 168:1911-1918.
• Tavernier J; Van der Heyden J; Verhee A; Brusselle G; Van Ostade X; Vandekerckhove J; North J; Rankin SM; et al. (1 Mar 2000). Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit. BLOOD. 95:1600-1607.
• Martin C; Bridger GJ; Rankin SM. (Aug 2006). Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro. Br J Haematol. 134:326-329. DOI.
• Gregory B; Kirchem A; Phipps S; Gevaert P; Pridgeon C; Rankin SM; Robinson DS. (1 Jun 2003). Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression. J Immunol. 170:5359-5366.
• Lloyd CM; Rankin SM. (Aug 2003). Chemokines in allergic airway disease. Curr Opin Pharmacol. 3:443-448.
• Rankin SM; Conroy DM; Williams TJ. (Jan 2000). Eotaxin and eosinophil recruitment: implications for human disease. Mol Med Today. 6:20-27.
• Palframan RT; Collins PD; Severs NJ; Rothery S; Williams TJ; Rankin SM. (2 Nov 1998). Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J Exp Med. 188:1621-1632.
• Palframan RT; Collins PD; Williams TJ; Rankin SM. (1 Apr 1998). Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood. 91:2240-2248.
• Humbles AA; Conroy DM; Marleau S; Rankin SM; Palframan RT; Proudfoot AE; Wells TN; Li D; et al. (18 Aug 1997). Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med. 186:601-612.
• Conroy DM; Humbles AA; Rankin SM; Palframan RT; Collins PD; Griffiths-Johnson DA; Jose PJ; Williams TJ. (1997). The role of the eosinophil-selective chemokine, eotaxin, in allergic and non-allergic airways inflammation. Mem Inst Oswaldo Cruz. 92 Suppl 2:183-191.

Conferences

• Rankin SM; Burdon PCE; Martin C. Role of adhesion molecules in regulating neutrophil mobilisation from the bone marrow. 45th Annual Scientific Meeting of the British-Society-for-Haematology, 11 Apr 2005 - 13 Apr 2005. 129:43-43. BLACKWELL PUBLISHING (Apr 2005).